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INTRODUCTION
It is well recognised that Barrett's oesophagus may progress to oesophageal adenocarcinoma through a dysplasia carcinoma sequence (1) . The risk of progression to adenocarcinoma depends on the presence and severity of dysplasia. In non-dysplastic Barrett's, the risk is only 0.1% per year (2) and the disease can be managed by surveillance alone. If high grade dysplasia (HGD) is present, the risk of progression increases to 5.6% per year (3) and active treatment is recommended (4).
Since April 2012, patients with a new diagnosis of oesophageal HGD in England have been eligible for inclusion in the National Oesophago-Gastric Cancer Audit (NOGCA). Hospitals prospectively collect data on patient characteristics, the results of the diagnostic endoscopy, planned treatment modality, and pathology of the tissue after endoscopic or surgical resection.
A challenge for the Audit has been to derive the number of HGD patients in England, and thereby monitor case-ascertainment. For patients diagnosed with oesophageal cancer, it is possible to derive the number of cases using the Hospital Episode Statistics (HES) administrative database (5) . HES uses the ICD-10 disease classification (6) to capture clinical conditions, and this contains clear codes for cancer diagnoses. Unfortunately, the standard ICD-10 system is not specific for different types of Barrett's oesophagus, and it is unclear how hospitals are using ICD-10 codes when patients have HGD. The aim of this study is to explore which diagnostic codes are currently being used to record oesophageal HGD in HES and to assess the consistency of this coding.
METHODS
This study used a linked dataset that combined information from the records of patients in the National Oesophago-Gastric Cancer Audit (NOGCA) and Hospital Episode Statistics (HES).
Patients were eligible for the study if they were diagnosed with oesophageal HGD in England Each HES record describes the episode of care during which a patient is under the care of a hospital consultant. Patient conditions are described using a primary diagnosis and up to 19 secondary diagnoses, and a record can hold up to 24 procedures (coded using the OPCS-4
Classification of Interventions and Procedures (7)). For each patient, we identified all HES records and then selected from these the episode whose start date was closest to the date of the HGD diagnosis recorded in NOGCA. Any endoscopic procedures occurring in these episodes were then identified (see appendix 1). If two episodes had the same start date, the record with most information relating to endoscopic procedures performed was selected.
Using this cohort of HGD patients, we then examined the pattern of primary and secondary ICD-10 diagnostic codes in the HES records, describing the common combinations of codes in terms of whether Barrett's oesophagus or related pathology was recorded.
RESULTS
The linked NOGCA-HES dataset contained 474 patients diagnosed with oesophageal HGD between 1 April 2013 and 31 March 2014. Among these, 22 patients did not have an endoscopy procedure recorded in the HES episode nearest the date of HGD diagnosis and these patients were excluded, leaving 452 patients for analysis.
The frequent combinations of diagnostic codes entered into the HES records are summarised in Table 1 . There were 293 (64.8%) patients who had a diagnosis of Barrett's oesophagus recorded in any diagnosis field, and this was the principal diagnosis in 225 records. Barrett's was the only condition entered in 200 (44.2%) HES records, highlighting that, in many cases, no additional code relating to oesophageal pathology was recorded.
Unexpectedly, the HES records of 59 patients (13.1%) contained no codes for pathology related to the oesophagus.
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DISCUSSION
Barrett's oesophagus is a known pre-malignant condition for oesophageal cancer (1), and the incidence of oesophageal cancer and Barrett's oesophagus has risen steeply over recent years (8) . While the management of this group of patients can be examined using national registries or clinical audits, a weakness of this approach is having confidence all eligible cases are being captured.
In other situations, a common approach to determine the case-ascertainment of a Registry is to compare it to the data in a national administrative hospital dataset. In England, this study demonstrates that the Hospital Episode Statistics database cannot fulfil this function in relation to patients with oesophageal HGD because the coding in HES records is variable.
The study found that a third of HGD patients reported to the NOGCA had no HES record of a diagnosis of Barrett's oesophagus at the time of diagnosis of HGD. Furthermore, where a diagnosis of Barrett's oesophagus was recorded, HES cannot be used to identify those patients who had the disease complicated by the presence of HGD. It was unexpected to find 57 patients with a diagnosis of cancer recorded in HES. This suggests that some patients either had a HGD record incorrectly submitted to the NOGCA (instead of a cancer record if both HGD and cancer were present on the initial biopsy, or the cancer was incorrectly coded in HES). We explored this issue by reviewing the pathology records of HGD patients who had an endoscopic mucosal resection (EMR). Among the 25 patients with a diagnosis of cancer in HES and an EMR pathology record in the NOGCA, 9 (36%) of these patients had no record of malignancy, which suggests a cancer diagnosis was incorrectly recorded in HES. Finally, 13.1% of patients had no diagnosis codes related to oesophageal pathology at all recorded in HES.
This study suffers from various limitations. First, as this study used data collected for a national audit, it was not possible to access individual patient records to confirm the accuracy of submitted data, in terms of date of diagnosis and pathology results.
Consequently it is possible if the date of diagnosis of HGD submitted to the audit was inaccurate then the corresponding HES episode selected for analysis may not have been the right one. Secondly, as previously mentioned, we were unable to confirm whether the Despite these limitations, the results highlight a significant problem for any national study looking at the management of HGD in England. The lack of a robust method for identifying these patients in a routine hospital database means it is not possible to estimate the incidence of the disease and the case ascertainment of national studies. This is of concern because early results from the NOGCA dataset showed that a third of patients with HGD were managed by surveillance alone (9) , and it may be that this figure is even higher due to the effect of selection bias if the cases submitted to NOGCA are not representative of the national population.
The main reason for this situation concerns the lack of a specific code for Barrett's oesophagus with HGD in the standard ICD-10 diagnosis codes. This limitation is not unique to ICD-10. For example, there is also no specific code for Barrett's oesophagus with HGD within SNOWMED. However, other countries have addressed this issue by producing a modified-version of ICD-10, such as the ICD-10-CM codes in the US . The ICD-10-CM system of coding allows for up to 7 characters to be recorded for each diagnostic field, incorporating greater detail about the diagnosis e.g. disease aetiology, anatomic site and laterality. In particular, the K22.7 code for Barrett's oesophagus has been augmented to include codes for Barrett's oesophagus with dysplasia (K22.719) and for Barrett's oesophagus with high grade and low grade dysplasia specifically (K22.711 and K22.710, respectively).
In the UK, the introduction of ICD-11 is planned for 2018. This will be an improvement because there are codes to distinguish between non dysplastic Barrett's oesophagus (EB90) and Barrett's with dysplasia (EB91). However, this will still be inadequate for studies of HGD, not least because low grade dysplasia can regress. We suspect this weakness is not limited to this clinical area, and consequently, we suggest that there would be considerable benefit to the UK if it adopted its own modification of the ICD-11 system for use in national databases such as HES. 
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